BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30333819)

  • 21. Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice.
    Uslu K; Coleman AS; Allman WR; Katsenelson N; Bram RJ; Alugupalli KR; Akkoyunlu M
    J Immunol; 2014 Apr; 192(8):3582-95. PubMed ID: 24646744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.
    Rickert RC; Jellusova J; Miletic AV
    Immunol Rev; 2011 Nov; 244(1):115-33. PubMed ID: 22017435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
    Abu-Rish EY; Amrani Y; Browning MJ
    Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation.
    Castigli E; Wilson SA; Elkhal A; Ozcan E; Garibyan L; Geha RS
    J Allergy Clin Immunol; 2007 Oct; 120(4):885-91. PubMed ID: 17689597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding.
    Hymowitz SG; Patel DR; Wallweber HJ; Runyon S; Yan M; Yin J; Shriver SK; Gordon NC; Pan B; Skelton NJ; Kelley RF; Starovasnik MA
    J Biol Chem; 2005 Feb; 280(8):7218-27. PubMed ID: 15542592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No evidence that soluble TACI induces signalling via membrane-expressed BAFF and APRIL in myeloid cells.
    Nys J; Smulski CR; Tardivel A; Willen L; Kowalczyk C; Donzé O; Huard B; Hess H; Schneider P
    PLoS One; 2013; 8(4):e61350. PubMed ID: 23620746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88.
    He B; Santamaria R; Xu W; Cols M; Chen K; Puga I; Shan M; Xiong H; Bussel JB; Chiu A; Puel A; Reichenbach J; Marodi L; Döffinger R; Vasconcelos J; Issekutz A; Krause J; Davies G; Li X; Grimbacher B; Plebani A; Meffre E; Picard C; Cunningham-Rundles C; Casanova JL; Cerutti A
    Nat Immunol; 2010 Sep; 11(9):836-45. PubMed ID: 20676093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
    Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
    Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection.
    Allman WR; Dey R; Liu L; Siddiqui S; Coleman AS; Bhattacharya P; Yano M; Uslu K; Takeda K; Nakhasi HL; Akkoyunlu M
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4094-103. PubMed ID: 26170307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of the cytokine receptor TNFRSF13B: A new therapeutic target for triple-negative breast cancer.
    Abo-Elfadl MT; Gamal-Eldeen AM; Ismail MF; Shahin NN
    Cytokine; 2020 Jan; 125():154790. PubMed ID: 31400636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation.
    Xia XZ; Treanor J; Senaldi G; Khare SD; Boone T; Kelley M; Theill LE; Colombero A; Solovyev I; Lee F; McCabe S; Elliott R; Miner K; Hawkins N; Guo J; Stolina M; Yu G; Wang J; Delaney J; Meng SY; Boyle WJ; Hsu H
    J Exp Med; 2000 Jul; 192(1):137-43. PubMed ID: 10880535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the BAFF/APRIL system on T cell function.
    Mackay F; Leung H
    Semin Immunol; 2006 Oct; 18(5):284-9. PubMed ID: 16931039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation.
    Ozcan E; Rauter I; Garibyan L; Dillon SR; Geha RS
    J Allergy Clin Immunol; 2011 Sep; 128(3):601-9.e1-4. PubMed ID: 21741080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
    Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
    J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells.
    Treml LS; Carlesso G; Hoek KL; Stadanlick JE; Kambayashi T; Bram RJ; Cancro MP; Khan WN
    J Immunol; 2007 Jun; 178(12):7531-9. PubMed ID: 17548587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells.
    Du SW; Jacobs HM; Arkatkar T; Rawlings DJ; Jackson SW
    J Immunol; 2018 Dec; 201(11):3258-3268. PubMed ID: 30373855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency.
    Knight AK; Radigan L; Marron T; Langs A; Zhang L; Cunningham-Rundles C
    Clin Immunol; 2007 Aug; 124(2):182-9. PubMed ID: 17556024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TACI haploinsufficiency protects against BAFF-driven humoral autoimmunity in mice.
    Jacobs HM; Arkatkar T; Du SW; Scharping NE; Woods J; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
    Eur J Immunol; 2021 Sep; 51(9):2225-2236. PubMed ID: 34146342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desensitization and treatment with APRIL/BLyS blockade in rodent kidney transplant model.
    Bath NM; Ding X; Wilson NA; Verhoven BM; Boldt BA; Sukhwal A; Reese SR; Panzer SE; Djamali A; Redfield RR
    PLoS One; 2019; 14(2):e0211865. PubMed ID: 30735519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus.
    Tran NL; Schneider P; Santiago-Raber ML
    Eur J Immunol; 2017 Apr; 47(4):713-723. PubMed ID: 28267197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.